Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
American Eagle Outfitters director Cary D. McMillan sold his entire stake in the company on April 6, 2026, disposing of 2,887 shares for $17.225 each, a transaction that generated $49,728. The stock has since traded up to $18.31 but remains down roughly 30% year-to-date despite a 69% gain over the prior 12 months. Filings show the sale was directly…
American Eagle Outfitters director Noel Joseph Spiegel sold 2,887 shares on April 6, 2026, for $17.32 per share, a transaction valued at roughly $50,002. Following the sale, Spiegel holds no direct shares in the company. The stock is trading above the sale price, and third-party analysis flags the shares as potentially undervalued even as analysts …
Director Robert Gries Jr. of Slide Insurance Holdings (SLDE) sold 56,424 shares of common stock on April 6 and 7, 2026, under a pre-arranged 10b5-1 trading plan, generating just over $1 million. The transactions occurred as the company reported robust fourth-quarter 2025 results, completed a $120 million repurchase program and received board approv…
Slide Insurance Holdings President and COO Lucas Shannon sold 36,791 shares of common stock between April 6 and April 8, 2026 under a prearranged 10b5-1 trading plan, generating approximately $663,573 in gross proceeds. The transactions occurred at prices between $18.00 and $18.09 per share. The company recently reported robust fourth-quarter 2025 …
Summary: Slide Insurance Holdings, Inc. (SLDE) Chief Executive Officer Bruce Lucas sold 371,991 shares of common stock between April 6 and April 8, 2026, under a prearranged 10b5-1 trading plan. The transactions generated $6.7 million at prices ranging from $18.00 to $18.09 per share. After the sales, Lucas continues to hold shares both indirectly …
Whitehawk Therapeutics CEO David James Lennon sold 260,427 shares of the company's common stock across three transactions from April 6 to April 8, 2026, generating approximately $899537. The disposals were executed to satisfy tax obligations from the vesting of restricted stock units. The shares were sold at prices between $3.40 and $3.51. After th…
Ghaffarian Enterprises, owner of roughly 10% of Intuitive Machines, sold 141,909 shares of Class A Common Stock on April 6, 2026, for about $3.29 million via a pre-arranged 10b5-1 plan. The transaction coincides with a sizable NASA contract award for the company's Nova-D lander and comes after quarterly results that missed consensus estimates. Mark…
Eli Berkovitch, Vice President, Chief Accounting Officer and Controller at Box Inc, sold 24,500 Class A shares on April 8, 2026, realizing $584,300. The transaction leaves him with 95,516 shares held directly. Box shares have fallen roughly 30% over the past six months and were trading at $23.18 at the time of reporting. Separately, Boxlight Corpor…
Box Inc.'s Chief Operating Officer Olivia Nottebohm sold 6,528 shares of Class A common stock on April 7, 2026, in a transaction valued at $157,128. The sale was carried out under a Rule 10b5-1 trading plan adopted July 9, 2025. After the transaction Nottebohm directly owns 487,488 shares, including holdings tied to time-based and performance-based…
Susan M. Byrne, Director Emerita of Westwood Holdings Group Inc., disposed of 3,498 shares of common stock between April 1 and April 8, 2026, under a Rule 10b5-1 trading arrangement. The trades totaled $57,878 at prices between $16.2117 and $16.8333. Westwood reported higher Q4 2025 revenues and sustained dividend payments, while the shares trade n…
On April 6, 2026, Box Inc director Evan Dana L sold 17,034 shares of Class A Common Stock for about $412,870 and on the same day exercised options to acquire an identical number of shares at $11.19 per share. After the transactions, Evan directly holds 113,525 shares, some of which are represented by restricted stock units subject to vesting and co…
Loveen Advani, Chief Financial Officer of Better Home & Finance Holding Co (NASDAQ:BETR), purchased 10 shares of the company's Class A Common Stock on April 8, 2026, spending $355. The company disclosed preliminary first-quarter 2026 funded loan volume of $1.64 billion, ahead of its guidance, and detailed an underwritten public offering expecte…
Finance of America Companies Inc. Chief Investment Officer Jeremy Prahm sold 5,228 Class A shares on April 6, 2026, for $93,225 under a Rule 10b5-1 trading plan. The transaction, together with recent company results and an upcoming accounting leadership change, arrives amid analyst coverage and continuing share-price volatility.
Orn Jonsson Sigurgeir, Chief Technology Officer of Better Home & Finance Holding Co (NASDAQ:BETR), bought 1,000 shares of Class A Common Stock on April 8, 2026, for a total of $36,089. The filings show prices between $36.05 and $36.09. The company reported first-quarter funded loans of $1.64 billion, beat its guidance range, announced a planned und…
Vishal Garg, chief executive of Better Home & Finance Holding Co (NASDAQ: BETR), acquired 10,000 Class A shares on April 8, 2026, for $350,519. The company also disclosed preliminary first-quarter funded loan volume of $1.64 billion, a significant increase versus guidance, alongside a planned underwritten equity offering, an expanded warehouse faci…
Adaptive Biotechnologies Chief Executive and Chairman Chad M. Robins sold 120,595 shares of common stock on April 6 and April 8, 2026, generating about $1.76 million in proceeds. The transactions occurred under a pre-established Rule 10b5-1 plan. The stock has rallied 94% over the past year per InvestingPro data, even as that platform flags ADPT as…
Advanced Micro Devices Chief Technology Officer Mark D. Papermaster sold 3,293 shares of AMD on April 6, 2026, for $225 per share, a transaction totaling $740,925. The filing shows he continues to hold more than 1.29 million shares directly and additional stakes held indirectly through family GRATs. The sale was made under a Rule 10b5-1 trading pla…
PubMatic Chief Financial Officer Steven Pantelick disposed of 16,282 shares of Class A common stock on April 6, 2026, in a trade executed under a pre-established Rule 10b5-1 plan. The sale, conducted at prices between $8.315 and $8.52, generated approximately $137,468 and reduced his direct ownership to 41,319 shares. Separately, the company report…
Julie Rubinstein, president and chief operating officer of Adaptive Biotechnologies Corp (ADPT), sold 68,261 shares of common stock between April 6 and April 8, 2026 under a pre-arranged 10b5-1 trading plan, generating approximately $990,503 in proceeds. During the same period she exercised options to acquire 41,325 shares. The company also reporte…
Exzeo Group CEO Paresh Patel acquired 2,000 shares of the company's common stock on April 7, 2026, spending $28,440 at $14.22 per share. The transaction raises his direct ownership to 1,602,013 shares. The purchase follows a 35% year-to-date decline in the stock that has since partially reversed, with shares trading at $15.83. Exzeo recently report…
Stitch Fix Chief Financial Officer David Aufderhaar sold 65,709 shares of Class A common stock on April 7, 2026, for $202,731 under a Rule 10b5-1 plan. The move comes as the stock has weakened in recent months, even as the company posted better-than-expected fiscal Q2 results and resumed a previously authorized buyback program.
Paulina Klimenko, Chief Growth Officer at PubMatic, sold 11,784 shares of the company’s Class A common stock on April 6, 2026, for roughly $99,492. The sale was executed under a pre-arranged Rule 10b5-1 plan and took place while PubMatic shares were trading near $8.42, below InvestingPro's fair value estimate of $9.90. The company reported robust f…
Jamie Iannone, president and chief executive officer of eBay Inc. (NASDAQ: EBAY), disposed of 35,000 shares of common stock across transactions on April 6 and 7, 2026, totaling roughly $4.07 million. The trades were carried out under a Rule 10b-5 trading plan established on November 20, 2025, and were disclosed on a Form 4 filing with the SEC. The …
Fady Ibraham Malik, Executive Vice President for Research & Development at Cytokinetics INC (NASDAQ: CYTK), sold 4,500 shares on April 7, 2026 for about $292,985 and simultaneously exercised options to acquire 4,500 shares for $37,900. After the transactions Malik holds 153,902 shares. The stock trades near its 52-week high as several analysts rais…
William Guyer, Corcept Therapeutics' Chief Development Officer, executed a sale of 20,000 shares of common stock on April 7, 2026, generating $819,400 at a weighted average price of $40.97. The transaction followed his exercise of options to acquire 20,000 shares at $21.65 per share. The company recently secured FDA approval for Lifyorli in a speci…
